Medicare Enrolled

Dr. Krikor Barsoumian, M.D.

Ophthalmology · San Jose, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2440 SAMARITAN DR, San Jose, CA 95124
4085594194
In practice since 2006 (19 years)
NPI: 1649296021 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barsoumian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barsoumian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Barsoumian

Dr. Krikor Barsoumian is an ophthalmology specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Barsoumian performed 1,712 Medicare services across 885 unique beneficiaries.

Between the years covered by Open Payments, Dr. Barsoumian received a total of $5,270 from 26 pharmaceutical and/or device companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Barsoumian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,712 Medicare services $5,270 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,712
Medicare services
Bottom 48% in CA for ophthalmology
885
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
 1,459 $112 $239
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
 119 $126 $284
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
 32 $67 $146
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
 30 $59 $125
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
 28 $39 $94
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
 27 $510 $1,678
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
 17 $309 $703
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
3.5% medium
94.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,270
Total received (2018-2024)
Avg $753/year across 7 years
Top 24% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,120 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$150 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,097
2023
$1,085
2022
$649
2021
$291
2020
$282
2019
$1,129
2018
$736

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$400
Bausch & Lomb Americas Inc.
$279
Alcon Vision LLC
$189
Mallinckrodt Hospital Products Inc.
$140
ABBVIE INC.
$88
Top 3 companies account for 79.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$688
Bausch & Lomb, a division of Bausch Health US, LLC
$617
Oyster Point Pharma, Inc.
$553
Bausch & Lomb Americas Inc.
$430
Aerie Pharmaceuticals, Inc.
$412
Amgen Inc.
$400
Horizon Therapeutics plc
$376
Allergan, Inc.
$230
Alcon Vision LLC
$213
Kala Pharmaceuticals, Inc.
$183
Mallinckrodt Hospital Products Inc.
$182
Shire North American Group Inc
$150
Genentech USA, Inc.
$125
AbbVie, Inc.
$125
Allergan Inc.
$124
ABBVIE INC.
$110
Sun Pharmaceutical Industries Inc.
$80
AbbVie Inc.
$69
E.R. Squibb & Sons, L.L.C.
$55
Glaukos Corporation
$32
OPTOS, INC.
$29
TISSUETECH, INC.
$20
Apellis Pharmaceuticals, Inc.
$18
GLAUKOS CORPORATION
$17
EYEVANCE PHARMACEUTICALS LLC
$17
Thea Pharma Inc.
$15
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · CEQUA · DURYSTA · ELIQUIS · ENVISTA · EYSUVIS · Humira · INVELTYS · ISTENT INJECT W · LOTEMAX SM · LUMIGAN · Lucentis · MIEBO · OZURDEX · P200DTx · PHOTREXA CROSS-LINKING KIT · PROKERA · PROLENSA · RESTASIS · Rhopressa · Rocklatan · TEPEZZA · TRAVATAN Z · TYRVAYA · TobraDex ST · VUITY · VYZULTA · XELPROS · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in San Jose?
Compare ophthalmologists in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
295
Per 100K population
15.5
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Barsoumian is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Barsoumian experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Barsoumian performed 1,459 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barsoumian receive payments from pharmaceutical companies?
Yes. Dr. Barsoumian received a total of $5,270 from 26 companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barsoumian's costs compare to other ophthalmologists in San Jose?
Dr. Barsoumian's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barsoumian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Ophthalmologists in San Jose
Browse ophthalmologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
By company
Oyster Point Pharma, Inc. Payments to Doctors
See all physicians who received payments from Oyster Point Pharma, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →